XOMA
1 follower
XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company’s portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas.
Org chart
James R. Neal
Collapse
Brad Sitko
Chief Investment Officer
Fred Kurland
Vice President, Finance and Chief Financial Officer
Jessica Holden
Group CFO
Joyce Chan
Vice President, Scientific Analysis
Lisa Christensen
Executive Assistant to the CEO
Thomas Burns
Senior Vice President, Finance and CFO
Christopher Baldwin
Vice President, Legal
Teams
View all
